SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-20-012254
Filing Date
2020-06-23
Accepted
2020-06-23 21:21:28
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp130858_4-coyne.html 4  
1 FORM 4 dp130858_4-coyne.xml 4 26527
  Complete submission text file 0000950103-20-012254.txt   27866
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022
Business Address
Coyne Terrance P. (Reporting) CIK: 0001814876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 20983650